PDB60 ASSESSMENT OF THE INTERVAL BETWEEN FIRST EXENATIDE CLAIM AND LAST PRIOR ORAL ANTIDIABETIC CLAIM

Autor: Misurski, D, Quimbo, RA, Hou, L, Pawaskar, MD, Wade, R
Zdroj: In Value in Health 2009 12(3):A108-A108
Databáze: ScienceDirect